Author: Agrati, Chiara; Alonzi, Tonino; De Santis, Rafaella; Castilletti, Concetta; Abbate, Isabella; Capobianchi, Maria Rosaria; D'Offizi, Gianpiero; Siepi, Francesca; Fimia, Gian Maria; Tripodi, Marco; Poccia, Fabrizio
                    Title: Activation of Vγ9Vδ2 T cells by non-peptidic antigens induces the inhibition of subgenomic HCV replication  Cord-id: 0am7p0qk  Document date: 2005_12_16
                    ID: 0am7p0qk
                    
                    Snippet: Hepatitis C virus (HCV) has evolved complex strategies to evade host immune responses and establish chronic infection. Since human Vγ9Vδ2 T lymphocytes play a critical role in the immune response against viruses, we analyzed their antiviral functions on Huh7 hepatoma cells carrying the subgenomic HCV replicon (Rep60 cells). In a transwell culture system, Rep60 cells were co-cultured with either PBMCs or highly purified γδ T cells stimulated by non-peptidic antigens. Vγ9Vδ2 T cell activatio
                    
                    
                    
                     
                    
                    
                    
                    
                        
                            
                                Document: Hepatitis C virus (HCV) has evolved complex strategies to evade host immune responses and establish chronic infection. Since human Vγ9Vδ2 T lymphocytes play a critical role in the immune response against viruses, we analyzed their antiviral functions on Huh7 hepatoma cells carrying the subgenomic HCV replicon (Rep60 cells). In a transwell culture system, Rep60 cells were co-cultured with either PBMCs or highly purified γδ T cells stimulated by non-peptidic antigens. Vγ9Vδ2 T cell activation was associated with a dramatic reduction of HCV RNA levels. Neutralizing antibodies targeting IFN-γ revealed a critical role for this cytokine in the inhibition of HCV replication. Interestingly, drugs already in clinical use, such as Phosphostim and Zoledronate, known to activate γδ T cells, were shown to induce the inhibition of HCV replication mediated by Vγ9Vδ2 T cells of HCV patients. Our data suggest that the therapeutic activation of Vγ9Vδ2 T lymphocytes may represent an additional strategy to inhibit HCV replication and to restore a T(h)1-oriented immune response in HCV-infected patients.
 
  Search related documents: 
                                Co phrase  search for related documents- absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
  - absence presence and adaptive immune response: 1, 2
  - absence presence and adaptive response: 1, 2, 3
  - absence presence and adoptive transfer: 1, 2
  - absence presence and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
  - absence presence and low inflammation: 1
  - absence presence and mabs neutralizing activity: 1, 2
  - absence presence and magnetic bead: 1, 2, 3
  - activation induce and acute phase: 1
  - activation induce and adaptive immune response: 1, 2, 3, 4
  - activation induce and adaptive response: 1, 2, 3, 4, 5
  - activation induce and adoptive transfer: 1, 2
  - activation lymphocyte and acute phase: 1, 2, 3, 4, 5, 6, 7
  - activation lymphocyte and adaptive immune response: 1, 2, 3, 4, 5
  - activation lymphocyte and adaptive response: 1, 2, 3, 4, 5, 6
  - activation lymphocyte and liver disease: 1
  - activation regulation and adaptive immune response: 1, 2
  - activation regulation and adaptive response: 1, 2
  - activation regulation and liver disease: 1
  
 
                                Co phrase  search for related documents, hyperlinks ordered by date